Showing 1 - 10 of 858
-lowering statins) to study the responses of physicians and patients to variation in the cost of drugs. In a sample of first-time statin …-income patients. Our analysis suggests that physicians can perceive the adherence elasticity of their patients and adjust their …, we present suggestive evidence that physicians learn about a patient's price sensitivity through their own experience of …
Persistent link: https://www.econbiz.de/10013225005
The trend towards giving consumers choice about their health plans has invited research on how good they actually are at making these decisions. The introduction of Medicare Part D is an important example. Initial plan choices in this market were generally far from optimal. In this paper, we...
Persistent link: https://www.econbiz.de/10012980659
deductible, while in the second firm pharmaceuticals were exempt. Employees in the first firm shifted the timing of drug … use of pharmaceuticals for chronic diseases. We compare two large firms where nearly all employees were switched to CDHPs … to firms with conventional health insurance plans. In the first firm's CDHP, pharmaceuticals were subject to the …
Persistent link: https://www.econbiz.de/10013028554
insurance plan that provided free health care to a non-linear, high deductible plan. The switch caused a spending reduction … high-deductible coverage. Consumers reduce quantities across the spectrum of health care services, including potentially … data environment to study how consumers respond to the complex structure of the high-deductible contract. We find that …
Persistent link: https://www.econbiz.de/10013013918
The overuse of medical services including antibiotics is often blamed on Physician Induced Demand. But since this … patients actively demanding antibiotics, by physicians believing that patients want antibiotics, or by physicians believing …
Persistent link: https://www.econbiz.de/10013104736
This paper analyzes pharmaceutical pricing between and within countries to achieve second best static and dynamic efficiency. We distinguish countries with and without universal insurance, because insurance undermines patients' price sensitivity, potentially leading to prices above second-best...
Persistent link: https://www.econbiz.de/10013064943
, however, considerably dampen demand. We find that uptake drops by 75 percent when the price of ITNs increases from zero to $0 …
Persistent link: https://www.econbiz.de/10012769676
demand, yet publicly-provided drug coverage typically involves uniform cost-sharing across drugs. We investigate how private … elasticities of demand across more than 150 drugs and across more than 100 therapeutic classes, as well as substantial … consumer cost-sharing for drugs or classes with more elastic demand. Our findings suggest that benefit design may be more …
Persistent link: https://www.econbiz.de/10012991674
Objective: The ratio of controller to reliever medication use has been proposed as a measure of treatment quality for asthma patients. In this study we examine the effects of plan level mean out-of-pocket asthma medication patient copayments and other features of benefit plan design on the use...
Persistent link: https://www.econbiz.de/10013221321
Insurance for prescription drugs is characterized by two types of cost-sharing: flat copayments and variable coinsurance. We develop a theoretical model to show that refill purchases of preventive drugs (compliance) are lower under coinsurance due to the consumer's exposure to variation in drug...
Persistent link: https://www.econbiz.de/10013322350